Dr. Roecker's area of interest lies in clinical therapeutics, or the treatment of a patient's diseases and/or disorders using both pharmacologic and non-pharmacologic approaches. Dr. Roecker's main interests are in the infectious disease and oncology disciplines, but general therapeutics is imperative to a pharmacist's knowledge base. Evidence-based medicine is crucial to up-to-date clinical therapeutics and allowing for appropriate dissemination of that information allows for an increased presence of pharmacy in the clinical medicine team.
Current Course Curriculum:
- Coordination of the Infectious Disease therapeutic module
- Second Year Profession of Pharmacy classes introducing professionalism, pharmacy practice, legal requirements, and pharmaceutical calculations
- Therapeutics of various disease states within the following modules: Patient Care and Assessment, Infectious Disease, Oncology/Gastrointestinal, and the Capstone Modules.
- Coordinate and teach the Infectious Disease Module in the Non-traditional Doctor of Pharmacy program
- Coordination and instruction of elective course, Drugs of Abuse, with B. Shane Martin, PharmD and Jeffery Talbot, PhD.
Collaborative practice agreement with Riverside Methodist Hospital in Columbus, Ohio practicing clinical pharmacy in the critical care and general medicine environments during the academic year. This was established in the fall quarter 2007-08.
Contingent pharmacist at Select Specialty Hospitals of Columbus, Ohio. This is a long term/acute care hospital.
- PharmD, Ohio Northern University, Ada, Ohio 2000
- Board Certification in Pharmacotherapy - December 2005 through present
- A Patient Chart– co-authored with Heather P. Roecker, PharmD. Copyrighted April 15, 2004 (TXu1-173-383)
- PopeSD, Roecker AM. Dalbavancin: a novel lipoglycopeptide antibacterial. Pharmacotherapy 2006; 26(7):908-18.
- Roecker AM, Allison JC, Kisor DF. Nelarabine: efficacy in the treatment of clinical malignancies. Future Oncology 2006; 2(4): 441-8.
- PopeSD, Roecker AM. Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections. Exp Opin Pharmacother 2007; 8(9): 1245-61.
- Roecker AM, Pope SD. Dalbavancin: a lipoglycopeptide antibacterial for gram-positive infections. Exp Opin Pharmacother 2008; 9(10): 1745-54.
- Overy AM, Shumate LA, Webb SM, Lehnert AE, Weisenberger MA, Detillion WA, Roecker AM. Options for breast cancer prevention in high-risk patients. The Pharmacy and Wellness Review 2010; 1(1): 4-6.
- Roecker AM, Stockert A, Kisor DF. Nelarabine in the treatment of refractory T-cell malignancies. Clin Med Insights: Oncol 2010; 4: 133-41.
- Ilenin, J, Fargo K, Berni L, Thatcher K, Swann C, Roecker A. Recent advances spark significant guideline change: antiretroviral therapy (ART) at high CD4+ counts in the treatment naïve patient. The Pharmacy and Wellness Review 2011; 2(1): 3-6.
- FargoK, Schoenberger E, Thatcher K, Hallman L, Roecker A, Mahfouz T. Will new MRSA guidelines make a difference in clinical outcomes? A comparison of United States and United Kingdom guidelines and outcomes. The Pharmacy and Wellness Review 2011; 2(2): 4-8.
Written Continuing Education Programs
- Roecker AM. Pneumonia treatment 2007. Continuing Education Article for Ohio Northern University Raabe College of Pharmacy website – available at http://www.onu.edu/pharmacy/pharmacy_ce. Posted: September 2007, credit expired September 2010.
- Rouch JL, Roecker AM. Exercise therapy in patient with type 2 diabetes mellitus: more motivation, less medication. Continuing Education Article for Ohio Northern University Raabe College of Pharmacy website – available at http://www.onu.edu/pharmacy/pharmacy_ce. Posted: June 2011.
- Roundtree K, Roecker AM. Over the counter medications used for cough and cold treatment in children. Continuing Education Article for Ohio Northern University Raabe College of Pharmacy website – available at http://www.onu.edu/pharmacy/pharmacy_ce. Posted: June 2011.
- Skouby A, Roecker AM. Amyotrophic lateral sclerosis: an overview for pharmacists. Continuing Education Article for Ohio Northern University Raabe College of Pharmacy website – available at http://www.onu.edu/pharmacy/pharmacy_ce. Posted: June 2011.
- Improving Patient Adherence: Tools for Success – submitted and funded through Ohio PACE for $73,950 May 2011 through April 2012